The association of traditional cardiovascular disease (CVD) risk factors with outcomes of Takotsubo syndrome (TTS) is not well-defined. This study examined how modifiable CVD risk factors affect composite cardiovascular outcomes in TTS hospitalizations. TTS admissions were identified using ICD-10 codes and compared for demographics and comorbidities using the 2019 National Inpatient Sample. A multivariable regression examined the association of traditional CVD risk variables with adverse composite cardiovascular outcomes in TTS, controlling for confounders including sociodemographic or hospital-level characteristics and other relevant comorbidities. A total of 16,055 (38.1%) of the 41,855 adult TTS admissions had composite cardiovascular outcomes (TACCO). The TACCO cohort was 81.5% white, 77.3% female, and 72 years old. This group had higher rates of diabetes and peripheral vascular disease (PVD). The results showed that a higher prevalence of diabetes with chronic complications (OR = 1.18) and complicated hypertension (HTN) (OR = 1.1) predicted TACCO, whereas tobacco use disorder (OR = 0.84), hyperlipidemia (OR = 0.76), and uncomplicated HTN (OR = 0.65) (p < 0.001) showed a paradoxical effect with TACCO. TACCO had fewer routine discharges (35.3% vs. 63.4%), longer stays (6 vs. 3 days), and higher median hospital costs (78,309 USD vs. 44,966 USD). This population-based study found that complicated HTN and DM with chronic complications are strongly associated with adverse cardiovascular outcomes in TTS hospitalizations. But still, some risk factors, such as hyperlipidemia and uncomplicated HTN, have counterintuitive effects that require further evaluation. To prevent cardiac events in TTS patients, traditional CVD risk factors must be addressed.
Hypertension is one of the leading causes of death worldwide, and has been increasing in prevalence. A subset of hypertensive patients has resistant hypertension: blood pressure above goal despite taking three or more antihypertensive medications. While the diagnosis of true resistant hypertension requires medication adherence, many studies have found suboptimal adherence or complete nonadherence in resistant hypertensive patients. There are many factors that affect medication adherence, some more prevalent in the treatment of resistant and refractory hypertension, such as complex and expensive medication regimens. The greatest hurdle in preventing nonadherence is accurately measuring and monitoring adherence. There are various methods of monitoring medication adherence, both directly and indirectly, including questionnaires, pill counting, and blood plasma or urinary testing. These methods vary substantially in accuracy and common usage. This review covers the factors that affect adherence in resistant hypertensive patients and the methods used to assess adherence in these patients.